In silico analysis of detrimental mutation in EPHB2 gene causing Alzheimer’s disease

Background EPHB2 (Ephrin Receptor B2) are instrumental in signaling pathways like MAPK mediating tumour suppression, progenitor cell proliferation etc. [1,2]. Previous research has investigated the possibility that disrupted EphB2NMDA R binding is relevant to the development of Alzheimer’s disease (AD), a condition that is characterized by severe synaptic impairment. Hence it can be inferred the role of EPHB2 and associated single nucleotide polymorphism is essential in studying the signaling pathways as well as neurodevelopmental processes associated with it. Studying the impact of the protein and the associated non-synonymous SNPS can also decode the role of genetic variations with respect to the role of the protein in the signaling pathway as well as susceptibility towards the disease. Materials and methods The protein sequence data for EPHB2 [Accession ID: P29323.5] was collected from NCBI protein sequence database. SNP information for the computational analysis was obtained from NCBI dbSNP and Ensemble Gene Browser. Structure of EPHB2 protein was obtained from RCSB Protein Data Bank. (PDB ID:2QBX). A point mutation in native EPHB2 protein at position 80, Arginine (R) to Histidine (H) was introduced using SPDB Viewer package (Figure 1). We used SIFT, Polyphen, PhD-SNP and MutPred tools in order to examine the lethal nsSNPs occurring in the EPHB2 coding region. We filtered the most pathological mutation by combining the scores of then above servers. We implemented SNP Effect 4.0 to examine the possible phenotypic consequences at molecular, cellular, and individual level. Volume of the recep